Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial CTSUTHOC30607-M

Title

ARandomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer

Principal Investigator(s)

John Murray

Details

  • Protocol No. CTSUTHOC30607-M
  • Open Date: 02/17/2010
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites: None Specified
  • Therapies: Molecular Targeted Agents / Immunotherapy / Biologics
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College
  • Secondary Protocol No: Not Specified

Description

None Provided.

Eligibility

Not provided. Please call for more information.